New Pharmacological Approaches in Heart Failure Therapy: Developments and Possibilities

Q: What does this research mean for the field?

The high failure rate of promising early-phase heart failure drugs in later trials may be attributed to flawed trial designs and the need for massive patient cohorts to prove outcome benefits. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

Joseph J. Cuthbert; Pierpaolo Pellicori; Parin Shah; Andrew L. Clark

doi:10.2217/fca-2016-0068

February 9, 2017ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam)

New Pharmacological Approaches in Heart Failure Therapy: Developments and Possibilities

View Full Paper

Ask AI

Bookmark

Share

Structured PICO

P

Population

Heart failure patients

I

Intervention

New pharmacological therapies

Implication

This review highlights the challenges in heart failure drug development and summarizes promising new pharmacological approaches.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Cuthbert et al. (2017) studied this question.

synapsesocial.com/papers/6a1d49fb164c88e7165ddb05 https://doi.org/10.2217/fca-2016-0068

Topics

Heart failure

HFrEF treatment

HFpEF management

View Full Paper

Ask AI

Bookmark

Share

New Pharmacological Approaches in Heart Failure Therapy: Developments and Possibilities

Structured PICO

Implication

Discussion

Cite This Study

Topics

New Pharmacological Approaches in Heart Failure Therapy: Developments and Possibilities

Structured PICO

Implication

Discussion

Cite This Study

Keep reading

Topics

Keep reading